arrow
C

Carlo Barone

irccs policlinico gemelli
H指数:39
被引数:5,838

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
2021-08-2018
OAAI
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (Apr, 10.1038/s41416-021-01334-9, 2021)

tepotinib在索拉非尼预处理的MET过表达的晚期肝细胞癌中的1b/2期试验 (4月,10.1038/s41416-021-01334-9,2021)

2021-06-021
OAAI
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
2021-03-058
PRE
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases
2020-07-0215
OAAI
Phase III study with FOLFIRI plus cetuximab versus FOLFIRI plus cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC
2018-05-306
PREAI
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
2016-06-0177
OAAI
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
2015-06-01162
OAAI
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
2015-03-0190
OAAI